ArticleJournal of virus eradication2024

Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial.

Jasmini Alagaratnam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.